港股異動 | 內地基金股東獲提早解禁禁售股份 諾誠健華-B(9969.HK)倒漲約4%
格隆匯7月5日丨諾誠健華-B(9969.HK)低開高走,現漲幅達約4%,報28.45港元,總市值427億港元。諾誠健華公佈,與內地基金正心谷資本達成協議解除部分禁售協議,自7月3日起生效。該中資基金持有公司3000萬股禁售股份,市值超過8億港元。較原定期限提早逾一個月解禁。此次率先解禁部分,相當於該基金持有該股的約四分一股份 。諾誠健華上週一(6月28日)股價創下29.1港元的上市新高。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.